Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

Episode 1: Update on the SLT/MED Study

L. Jay Katz, MD, provides an update on the forthcoming randomized clinical trial comparing selective laser trabeculoplasty with topical medical therapy using prostaglandin analogues as initial monotherapy for glaucoma. According to Dr. Katz, he and his fellow researchers found the two treatment options to be similarly efficacious out to 1 year.

Dr. Katz also addresses the complex question of why ophthalmologists as a group have hesitated to embrace laser trabeculoplasty as a first-line intervention, despite the shortcomings of topical medical therapy such as noncompliance and side effects.

55 / 55 Series: Glaucoma Today Journal Club

More Videos in this Series